Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - CAPITAL EXPENDITURES
Capital Expenditures VRDN - Viridian Therapeutics, Inc.
-898 K
LAST VALUE
-63.00%
2 YEAR CAGR
-15.08%
5 YEAR CAGR
-68.84%
10 YEAR CAGR